National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

Case
No judgment structure available for this case.
 

STATUTORY RULES

1971 No.

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1970.*

W HEREAS it is provided by sub-section (4.) of section 101 of the National Health Act 1953-1970 that a drug or medicinal preparation that was not a pharmaceutical benefit under the National Health Act 1953-1958 immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:

AND WHEREAS that Committee has recommended to the Minister that the following additional drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953-1970, namely, the drugs and medicinal preparations specified in the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:

NOW THEREFORE I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1970.

Dated this first day of April, 1971.

Paul Hasluck

Governor-General.

By His Excellency's Command,

Sgd.“I.J. Greenwood”

Minister of State for Health.

Amendments of the National Health (Pharmaceutical Benefits) Regulations 

Commencement.

1. These Regulations shall come into operation on the first day of April, 1971.

First, Second, Third, Fourth and Fifth Schedules.

2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

FIRST SCHEDULE Regulation 10.

Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as or, except as specially provided, used in Pharmaceutical Benefits

1. Acetomenaphthone

2. Acetomenaphthone Tablets

3. Acetrizoic Acid

4. Alcohol Dehydrated

4a. Alcohol (95%)

4b. Allopurinol

5. Almond Oil

6. Aluminium Hydroxide Tablets

6a. Amethocaine Hydrochloride

7. Amitriptyline Injection

* Notified in the Commonwealth Gazette on  197l.

  Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1961. Nos. 12, 57 and 135; 1965, Nos, 51, 151 and 152; 1960, Nos. 80 and 144; 1967, Nos. 67, 116 and 158; 1968, Nos. 44, 76, 88 and 146; 1969, Nos, 44, 107 and 185; and 1970, Nos. 39, 94, 119 and 186.

11874/71—Price 30c  10/18.3.1971

First Schedule—continued

8. Amodiaquine Hydrochloride

9. Amphetamine Sulphate

10. Amphetamine Sulphate Tablets

11. Amylobarbitone Sodium Tablets

12. Antazoline Hydrochloride

12a. Antazoline Tablets

13. Antimony Sodium Tartrate

14. Antimony Sodium Tartrate Injection

15. Apomorphine Hydrochloride

16. Apomorphine Injection

16a. Arachis Oil

17. Aspirin Phenacetin and Codeine Tablets

18. Aspirin Phenacetin and Codeine Tablets Soluble

18a. Azathioprine

19.  Bacillus Calmette-Guérin Vaccine

20.  Barium Sulphate

20a. Beclomethasone Dipropionate

21.  Belladonna Herb

22.  Belladonna Herb, Powdered

23.  Bemegride

23a. Bendrofluazide

23aa. Bemegride Injection

24.  Benzhexol Hydrochloride

25.  Benztropine Mesylate

26.  Betamethasone Sodium Phosphate Tablets

26a. Bethanidine Sulphate

27. Bisacodyl

28. Bisacodyl Suppositories

29. Bisacodyl Tablets

30. Botulinum Antitoxin

30a. Bupivacaine Hydrochloride

31. Busulphan

32. Butobarbitone

33. Butylated Hydroxyanisole

34. Butylated Hydroxytoluene

35. Caffeine Hydrate

36. Calciferol Solution

37. Calcium Cyclamate

37a. Camphor

38. Caramiphen Hydrochloride

39. Caramiphen Tablets

40. Caraway

41. Carbimazole

42. Carbon Dioxide

43. Carbromal Tablets

44. Cardamom Fruit

45. Cascara

47. Catgut, Sterilised, Surgical

48. Cellulose, Oxidised

49. Cetylpyridinium Chloride

50. Chlorambucil

51. Chlordiazepoxide Capsules

52. Chlordiazepoxide Hydrochloride

52a. Chloroform

52b. Chlormadinone Acetate

53. Chloroquine Phosphate

54. Chloroquine Phosphate Injection

55. Chloroquine Sulphate

56. Chlorothiazide

57. Chlorotrianisene

58. Chlorotrianisene Capsules

59. Chlorphenesin

60. Chlorproguanil Hydrochloride

61. Chlorproguanil Tablets

62. Chlorpropamide

62a. Chloretracycline Hydrochloride

63. Chlorthalidone

65. Choline Theophyllinate Tablets

66. Cinchocaine Hydrochloride

67. Cinnamon

67a. Clofibrate

69. Cochineal

70. Colchicine

71. Colchicum Corm

72. Colchicum Liquid Extract

73. Colistin Tablets

73a. Concentrated Peppermint Water

74. Coriander

75. Coriander Oil

76. Corticotropin

76a. Cottonseed Oil

76aa. Corticotropin Injection

76ab. Corticotropin Gelatin Injection

76ac. Corticotropin Zinc Hydroxide Injection

77. Cresol and Soap Solution

78. Cresol

79. Crotamiton

80. Cyanocobalamin

81. Cyanocobalamin (57 Co)

82. Cyanocobalamin (58 Co)

83. Cyclamic Acid

84. Cyclizine Tablets

85. Cyclobarbitone Calcium

86. Cyclomethycaine Sulphate

81. Cyclopenthiazide

88. Cyclopentolate Hydrochloride

89. Cyclopropane

90. Cycloserine

91. Dapsone

92. Dequalinium Acetate

93. Dequalinium Chloride

94. Desipramine Hydrochloride

96. Dexamphetamine Sulphate

97. Dexamphetamine Tablets

98. Dextran 110 Injection

99. Dextromethorphan Hydrobromide

100. Dextromethorphan Tablets

101. Dextropropoxyphene Capsules

102. Dextropropoxyphene Hydrochloride

103. Dextropropoxyphene Napsylate

103b. Dextrose Monohydrate

104. Diamorphine Hydrochloride

105. Diamorphine Injection

105a. Diazepam Capsules

106. Dibromopropamidine Isethionate

107. Dichloralphenazone

108. Dichlorophen

109. Dichlorphenamide

110. Dicthylcarbamazine Citrate

111. Dicthylcarbamazine Tablets

112. Digitalis Leaf

113. Digitalis Prepared

114. Digitoxin

114a. Digitoxin Tablets

114b. Dihydrocodeine Injection

114c. Dihydrocodeine Tablets

115. Diloxanide Furoate

115a. Dilute Alcohols

116. Dimenhydrinate

117. Dimenhydrinate Injection

118. Dimenhydrinate Tablets

119. Dimercaprol

120. Dimethisterone

121. Dimethisterone Tablets

122. Diodone Injection

123. Diphtheria and Pertussis Vaccine

First Schedule—continued

124. Diptheria, Tetanus and Poliomyelitis Vaccine

125. Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine

126. Dipipanone Hydrochloride

127. Dipipanone Injection

128. Dodecyl Gallate

129. Domiphen Bromide

129a. Dried Human Albumin

330. Dusting Powder Absorbable

131. Edrophonium Chloride

131a. Eltor Vaccine

132. Emetine and Bismuth Iodide

133. Emetine Hydrochloride

134. Erythromycin

134a. Ethacrynic Acid

135. Ethchlorvynol

135a. Ether Anaesthetic

136. Ethinyloestradiol

137. Ethionamide

138. Ethisterone

139. Ethopropazine Hydrochloride

140. Ethotoin

141. Ethyl Chloride

142. Ethyl Oleate

143. Ethylenediamine Hydrate

143A. Eucalyptus Oil

143b. Ethynodiol Diacetate

144. Eugenol

145. Ferric Citrate (59 Fe) Injection

146. Ferrous Fumarate

147. Ferrous Succinate Tablets

148. Fludrocortisone Acetate

150. Fluoxymesterone

151. Gallamine Triethiodide

152. Gallamine Injection

153. Gamma Benzene Hexachloride

154. Gelatin Sponge, Absorbable

155. Gentian

156. Ginger

157. Gold (193 Au) Injection

159. Halothane

160. Helium

161. Heparin

161a. Hexachlorophane

162. Hexylresorcinol

163. Histamine Acid Phosphate

164. Histamine Acid Phosphate Injection

164a. Human Albumin

165. Human Blood, Whole

166. Human Red Blood, Corpuscles, Concentrated

167. Human Fibrin Foam

168. Human Fibrinogen

169. Human Normal Gamma Globulin Injection

170. Human Plasma, Dried

171. Human Plasma Protein Fraction

172. Human Plasma Protein Fraction, Dried

173. Human Serum, Dried

174. Human Thrombin

175. Hydrochlorothiazide

177. Hydrocortisone Hydrogen Succinate

178. Hydrocortisone Sodium Succinate

179. Hydroflumethiazide

180. Hydrogen Peroxide Solution, Strong

181. Hydroxocobalamin

182. Hydroxychloroquine Sulphate

183. Hyoscine Injection

184. Hyoscine Eye Ointment

184a. Hyoscine Tablets

185. Hyoscyamus

186. Hyoscyamus Dry Extract

187. Indigo Carmine

187a. Influenza Vaccine

187aa. Industrial Methylated Spirit

187b. Inulin

187c. Inulin Injection

188. lodinated (131I) Human Serum Albumin Injection

189. Iodipamide Meglumine Injection

190. Iodised Oil Fluid Injection

191. Iopanoic Acid

192. Iopanoic Acid Tablets

193. Iophendylate Injection

194. Iothalamic Acid

195. Ipecacuanha, Prepared

196. Isocarboxazid

197. Isocarboxazid Tablets

198. Isoniazid

199. Isopropyl Alcohol

199a. Laevulose

201. Lemon Peel, Dried

202. Levallorphan Injection

203. Levorphanol Tartrate

204. Lignocaine and Adrenaline Injection

205. Liothyronine Sodium

206. Liquorice

206a. Lithium Carbonate

206b. Lithium Carbonate Tablets

207. Lucanthone Hydrochloride

208. Lucanthone Tablets

209. Lynoestrenol

210. Magnesium Stearate

210a. Maize Oil

211. Male Fern

212. Maleic Acid

213. Measles Vaccine (Inactivated)

214. Measles Vaccine (Live Attenuated)

215. Mecamylamine Hydrochloride

215a. Mefenamic Acid

215b. Mefenamic Acid Capsules

215c. Metrestrol Acetate

216. Meglumine Iothalamate Injection

217. Melarsoprol

218. Melarsoprol Injection

219. Mepacrine Hydrochloride

220. Mephentermine Sulphate

221. Meprobamate

222. Meprobamate Tablets

222a. Mepyramine Maleate

222b. Mepyramine Tablets

223. Mercaptopurine

224. Mersalyl Acid

225. Mestranol

226. Metaraminol Tartrate

227. Methadone Hydrochloride

228. Methandienone

229. Methicillin Sodium

230. Methohexitone Injection

231. Methoin

232. Methoserpidine

233. Methoserpidine Tablets

234. Methoxyflurane

235. Methyl Hydroxybenzoate

236. Methylamphetamine Hydrochloride

237. Methylamphetamine Injection

238. Methylamphetamine Tablets

239. Methyldopa

First Schedule—continued

240. Methylergometrine Maleate

240a. Methylprednisoione Tablets

241. Methylthiouracil

242. Methylthiouracil Tablets

243. Methyprylone

244. Methyprylone Tablets

245. Metronidazole

246. Nalorphine Hydrobromide

247. Nandrolone Decanoate

248. Nandrolone Phenylpropionate

249. Naphazoline Hydrochloride

250. Nealbarbitone

251. Nealbarbitone Tablets

252. Neostigmine Bromide

253. Nialamide

254. Nialamide Tablets

255. Niclosamide

256. Nicotinic Acid

257. Nicoumalone

258. Nikethamide

259. Nikethamide Injection

260. Nitrous Oxide

261. Norethandrolone

262. Norethandrolone Tablets

263. Norethisterone

266. Norethynodrel

267. Noscapine

268. Novobiocin Calcium

269. Novobiocin Sodium

270. Novobiocin Tablets

271. Nux Vomica

272. Oetyl Gallate

273. Oestradiol Benzoate

273a. Olive Oil

274. Opium

275. Opium, Powdered

276. Orange Peel, Dried Bitter

277. Orphenadrine Hydrochloride

278. Oxygen

279. Oxyphenbutazone

280. Oxyphenbutazone Tablets

281. Oxyphencyclimine Hydrochloride

282. Oxytetracycline Tablets

283. Oxytocin Tablets

284. Paramethadione

285. Paramomycin Capsules

286. Paramomycin Sulphate

287. Pempidine Tartrate

287a. Penicillamine

288. Penicillamine Hydrochloride

289. Pentamidine Isethionate

290. Pentamidine Injection

291. Pentolinium Tartrate Tablets

291a. Peppermint Oil

292. Percutaneous Bacillus Calmette-Guérin Vaccine

293. Perphenazine

294. Perphenazine Tablets

295. Pethidine Tablets

296. Phenacetin

296a. Phenazocine Hydrobromide

296b. Phenazocine Injection

296c. Phenazocine Tablets

297. Phenelzine Sulphate

298. Phenelzine Tablets

299. Phenindamine Tartrate

300. Phenindione

301. Phenmetrazine Hydrochloride

302. Phenmetrazine Tablets

303. Phenolphthalein Tablets

304. Phenolsulphonphthalein

304a. Phenoxybenzamine Capsules

305. Phenoxybenzamine Hydrochloride

306. Phenoxymethylpenicillin

306a. Phenoxymethylpenicillin Potassium

307. Phentolamine Mesylate

308. Phentolamine Injection

310. Phytomenadione Capsules

311. Phytomenadione Tablets

312. Piperazine Citrate

313. Piperazine Phosphate Tablets

314. Poldine Methylsulphate

315. Poldine Tablets

316. Poliomyelitis Vaccine (Inactivated)

317. Poliomyelitis Vaccine (Oral)

317a. Potassium Bromide

318. Potassium Chloride Injection

319. Prednisolone Sodium Phosphate Injection

320. Prednisolone Pivalate Injection

322. Prednisone Acetate

323. Primaquine Phosphate

324. Probenecid

325. Procainamide Tablets

326. Procaine and Adrenaline Injection

327. Prochlorperazine Maleate

328. Prochlorperazine Mesylate

330. Procyclidine Hydrochloride

331. Progesterone

332. Proguanil Hydrochloride

333. Promazine Hydrochloride

334. Promazine Injection

335. Promazine Tablets

336. Promethazine Theoclate

337. Promethazine Theoclate Tablets

338. Propranolol Hydrochloride

339. Propyl Gallate

340. Propyliodone

341. Propyliodone Injection

342. Propyliodone Oily Injection

343. Propylthiouracil

344. Pyrazinamide

345. Pyridostigmine Bromide

346. Pyrimethamine

347. Pyroxylin

348. Quillaia

349. Quinine Dihydrochloride Injection

350. Rabies Antiserum

351. Rabies Vaccine

352. Sesame Oil

353. Soda Lime

354. Sodium Acetate

355. Sodium Acetrizoate Injection

357. Sodium Antimonylgluconate

358. Sodium Antimonylglnconate Injection

359. Sodium Aurothiomalate

360. Sodium Bicarbonate Compound Tablets

361. Sodium Bromide

362. Sodium Calciumedetate

363. Sodium Chromate (51 Cr) Solution

364. Sodium Citrate Tablets

365. Sodium Cyclamate

366. Sodium Diatrizoate

367. Sodium Diatrizoate Injection

368. Sodium Fluoride

369. Sodium Fusidale Capsules

370. Sodium Iodide (131 I) Injection

370a. Sodium Iodide (125 I) Solution

First Schedule—continued

371. Sodium Iodide (131 I) Solution

372. Sodium Iodohippurate (131 I) Injection

373. Sodium Iothalamate Injection

374. Sodium Lauryl Sulphate

375. Sodium Phosphate (32 P) Injection

376. Sodium Stibogluconate

377. Sodium Stibogluconate Injection

378. Solapsone

379. Solapsone Tablets

380. Spironolactone

381. Staphylococcus Antitoxin

382. Stibophen

383. Stibophen Injection

384. Stramonium

385. Sulphadiazine Sodium

386. Sulphadimethoxine

386a. Sulphadimidine Injection

387. Sulphadimidine Sodium

388. Sulphamethizole

389. Sulphamethoxydiazine

390. Sulphamethoxypridazine

391. Sulphapyridine

392. Sulphinpyrazone

393. Sulphobromophthalein Sodium

393a. Sulphomyxin Injection

394. Sulphomyxin Sodium

395. Sulthiame

396. Suramin

397. Suramin Injection

398. Suxamethonium Chloride

399. Testosterone

401. Testosterone Phenylpropionate Injection

403. Tetanus and Pertussis Vaccine

404. Tetanus Vaccine (Alum Precipitated)

405. Tetanus Vaccine (Simple Solution)

406. Tetrachlorocthylene

407. Tetrachloroethylene Capsules

407a. Tetracycline Tablets

408. Thiomersal

409. Thiopentone Sodium

410. Thiopentone Injection

411. Thioridazine Hydrochloride

412. Thyroid

413. Thyroxine Sodium

413a. Tolnaftate

414. Tolazoline Hydrochloride

414a. Tolazoline Tablets

415. Tolbutamide

416. Tranylcypromine Sulphate

417. Tranylcypromine Tablets

419. Triamterene Capsules

420. Trichloroethylene

421. Tricyclamol Chloride

422. Tryparsamide

423. Tryparsamide Injection

424. Tuberculin, Old

425. Tuberculin Purified Protein Derivative

426. Tubocurarine Chloride

427. Tubocurarine Injection

427a. Turpentine Oil

428. Typhoid-Paratyphoid A and B

429. Typhoid-Paratyphoid A and B and Cholera Vaccine

430. Typhoid-Paratyphoid A and B and Tetanus Vaccine

431. Typhoid-Paratyphoid A, B and C Vaccine

432. Undccenoic Acid

433. Urea

434. Urea Injection

435. Vancomycin Hydrochloride

436. Vancomycin Injection

437. Vinyl Ether

438. Vitamin A Ester Concentrate

439. Yellow Fever Vaccine

440. Zinc Undecenoate

441. Zinc Undecenoale Ointment

SECOND SCHEDULE Regulation 10 (3.)

Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations

First Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Allowable Compounds (if any)

1

Acepifylline .........................

—

2

Acetylsulphafurazole ...........

—

3

Acetylcysteine .....................

—

4

Acrylic Resin .......................

—

5

Adrenaline Hydrochloride ....

—

6

Albumaid XP .......................

—

7

Aluminium Sodium Silicate ..

—

8

Amino Acids .......................

Amino Acids with Sorbitol

Amino Acids with Sorbitol and Alcohol

9

Amphotericin B ...................

Tetracycline, B.P.C. with buffering agent and Amphotericin B

10

Ampicillin ...........................

—

11

Ampicillin Trihydrate ...........

—

12

Antazoline Sulphate .............

Naphazoline Nitrate with Antazoline Sulphate

Second Schedule—continued

First Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Allowable Compounds (if any)

13

Ascorbic Acid.........................

Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Vitamin D and Ascorbic Acid

Ferrous Sulphate mixture and Ferrous Sulphate mixture C.F. of the Australian Pharmaceutical Formulary

Ferrous Sulphate mixture Prescribers List

Ferrous Sulphate mixture Prescribers List Children's Section

14

Attapulgite .............................

Dihydrostreptomycin Sulphate with Pectin, Dried Aluminium Hydroxide Gel and Attapulgite

15

Bacitracin ..............................

Neomycin Sulphate with Polymyxin B Sulphate and Bacitracin

16

Bacitracin Zinc .......................

Neomycin Undecenoate with Bacitracin Zinc

Polymyxin B Sulphate with Neomycin Sulphate and Bacitracin Zinc

17

Belladonna Herb, Prepared ......

Phenobarbitone with Belladonna Herb, Prepared

18

Belladonna, Dry Extract ..........

Phenolphthalein with Aloin, Strychnine, B.P.C. 1959, Ipecacuanha and Dry Extract of Belladonna

19

Betamethasone .......................

Betamethasone Acetate with Betamethasone

20

Betamethasone Acetate ...........

Betamethasone with Betamethasone Acetate

21

Betamethasone Sodium Phosphate

—

22

Betamethasone Phosphate .......

—

23

Betamethasone Valerate ..........

Clioquinol with Betamethasone Valerate

24

Brompheniramine Maleate ......

—

25

Buclosamide ..........................

Salicylic Acid with Buclosamide

Salicylic Acid with Hydrocortisone Acetate and Buclosamide

26

Calciferol ...............................

—

27

Calcium Di-Oxytetracycline ....

—

28

Capsicum Olcoresin ................

Cascara Dry Extract with Phenolphthalein, Sodium Tauroglycocholate, B.P.C. 1954 and Capsicum Oleoresin

29

Carbachol ..............................

Hypromellose 4500 with Carbachol

31

Carbinoxamine Maleate ..........

—

32

Carbromal ..............................

Carbromal with Pentobarbitone Sodium

33

Cascara Dry Extract ................

Phenolphthalein with Capsicum Oleoresin, Sodium Tauroglycocholate, B.P.C. 1954 and Cascara Dry Extract

34

Chloramine, B.P.C. .................

—

35

Chloramphenicol ....................

Polymyxin B Sulphate with Chloramphenicol

Hydrocortisone Acetate with Chloramphenicol

36

Chloramphenicol Palmitate, B.P.C.

—

37

Chloramphenicol Stearate .......

—

38

Chlorhexidine Gluconate ........

—

40

Chlorpheniramine Maleate ......

—

41

Chlorpromazine Hydrochloride

—

42

Chlortetracycline Hydrochloride

—

43

Choline Theophyllinate ...........

Guaiphenesin with Choline Theophyllinate

44

Clemizole Tannate ..................

—

45

Clioquinol ..............................

Betamethasone Valerate with Clioquinol

Flumethasone Pivalate with Clioquinol

46

Colistin Sulphate ....................

Neomycin Sulphate with Colistin Sulphate

47

Cortisone Acetate ...................

—

48

Cyclizine Hydrochloride .........

Ergotamine Tartrate with Caffeine and Cyclizine Hydrochloride

49

Cymogran ..............................

—

50

Cyproheptadine Hydrochloride

—

51

Danthron ................................

Dioctyl Sodium Sulphosuccinate, B.P.C. with Danthron

52

Demecarium Bromide .............

—

53

Demethylchlortetracycline Hydrochloride

Nystatin with Demethylchlortetracycline Hydrochloride

54

Dexamethasone ......................

Framycetin Sulphate with Gramicidin and Dexamethasone

Second Schedule—continued

First Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Allowable Compounds (if any)

55

Dexamethasone Metasulphobenzoate

Framycetin Sulphate with Gramicidin and Dexamethasone Metasulphobenzoate

56

Dexchlorpheniramine Maleate.........

—

57

Dextrans .......................................

Dextrose with Dextrans

Sodium Chloride with Dextrans

58

Diazepam ......................................

—

59

Dichloralphenazone .......................

—

60

Dicyclomine Hydrochloride ...........

Doxylamine Succinate with Pyridoxine Hydrochloride and Dicyclomine Hydrochloride

61

Dienoestrol ....................................

—

62

Diethanolamine Fusidate ................

—

63

Digoxin .........................................

—

63a

Dihydrocodeine Acid Tartrate

—

64

Dihydrostreptomycin Sulphate, B.P. 1958

Attapulgite with Pectin, Dried Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958

Kaolin with Pectin, Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958

65

Dihydrotachysterol ........................

—

66

Dimethiconc, B.P.C. ......................

—

67

Dioctyl Sodium Sulphosuccinatc, B.P.C

Danthron with Dioctyl Sodium Sulphosuccinate, B.P.C.

Oxyphenisatin Acetate with Dioctyl Sodium Sulphosuccinatc B.P.C.

68

Diphenhydramine Hydrochloride

Ergotamine Tartrate with Caffeine Citrate and Diphenhydramine Hydrochloride

69

Diphenylpyraline Hydrochloride

—

70

Diphtheria Vaccine ........................

Diphtheria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)

Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine

71

Doxycycline Hyclate ......................

—

72

Doxylamine Succinate ...................

Dicyclomine Hydrochloride with Pyridoxine Hydrochloride and Doxylamine Succinate

73

Ecothiopate Iodide .........................

—

75

Ergometrine Maleate ......................

Oxytocin with Ergometrine Maleate

76

Ergotamine Tartrate .......................

Caffeine with Ergotamine Tartrate

Caffeine with Cyclizine Hydrochloride and Ergotamine Tartrate

Caffeine Citrate with Diphenhydramine Hydrochloride and Ergotamine Tartrate

Caffeine with Meclozine Hydrochloride and Ergotamine Tartrate

77

Erythromycin Estolate ....................

—

78

Erythromycin Stearate ....................

—

79

Ethosuximide ................................

—

80

Ferric Hydroxide ...........................

—

81

Ferrous Aminoacetosulphate ..........

—

82

Ferrous Succinate ..........................

__

83

Flumethasone Pivalate ...................

Clioquinol with Flumethasone Pivalate

84

Fluphenazine Hydrochloride ...........

—

85

Framycetin Sulphate ......................

Eight Kaolin with Framycetin Sulphate

Dexamethasone with Framycetin Sulphate and Gramicidin

Gramicidin and Dexamethasone Metasulphobenzoate with Framycctin Sulphate

86

Galactomin, Formula No. 17

—

87

Galactomin, Formula No. 19

—

88

Glucose Indicator, Urine ................

—

89

Goat's Milk, Dehydrated ................

—

90

Goat's Milk ....................................

—

91

Gramicidin ....................................

Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin

Second Schedule—continued

First Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Allowable Compounds (if any)

91—cont.

Neomycin Sulphate with Thonzonium Bromide, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Gramicidin

Framycetin Sulphate with Dexamethasone and Gramicidin

Framycetin Sulphate with Dexamethasone Metasulphobenzoate and Gramicidin

Neomycin Sulphate with Nystatin, Triamcinolone Acetonide and Gramicidin

92

Guaiphenesin, B.P.C. .............

Theophylline with Guaiphenesin, B.P.C.

93

Glucose Indicator, Blood .......

—

95

Hydrocortisone ......................

Polymyxin B Sulphate with Neomycin Sulphate and Hydrocortisone

1, 2–Propanediol Diacetate, Acetic Acid, Propylene Glycol and Hydrocortisone

Neomycin Sulphate with Hydrocortisone

Natamycin with Neomycin Sulphate and Hydrocortisone

96

Hydrocortisone Acetate .........

Buclosamide with Salicylic Acid and Hydrocortisone Acetate

Neomycin Sulphate with Hydrocortisone Acetate

Neomycin Sulphate with Gramicidin, Thonzonium Bromide, Thonzylamine Hydrochloride and Hydrocortisone Acetate

Oxytetracycline Hydrochloride with Hydrocortisone Acetate

Chloramphenicol with Hydrocortisone Acetate

98

Hyoscine Hydrobromide ........

Hypromellose 4500 with Hyoscine Hydrobromide

Papaveretum with Hyoscine Hydrobromide

Pethidine Hydrochloride with Hyoscine Hydrobromide

Morphine Sulphate with Hyoscine Hydrobromide

99

Idoxuridine ...........................

—

100

Ipecacuanha ..........................

Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine, B.P.C. 1959 and Ipecacuanha

101

Isoniazid ...............................

Sodium Aminosalicylate with Isoniazid

102

Isoprenaline Hydrochloride ....

—

103

Kanamycin Sulphate, B.P.C. ..

—

105

Lauryl Dimethylbenzyl Ammonium Chloride

'TERTC' N8 with Lauryl Dimethylbenzyl Ammonium Chloride

106

Levallorphan Tartrate ............

Pethidine Hydrochloride with Levallorphan Tartrate

107

Lignocaine Hydrochloride ......

Polymyxin B Sulphate with Propylene Glycol and Lignocaine Hydrochloride

108

Lincomycin Hydrochloride ....

—

109

Lofenalac ..............................

—

110

Lypressin ..............................

—

111

Magnesium Aluminium Hydroxide

—

112

Magnesium Chloride .............

Sodium Chloride with Ammonium Chloride, Potassium Chloride and Magnesium Chloride

Sodium Chloride with Potassium Chloride, Sodium Lactate and Magnesium Chloride

113

Magnesium Hydroxide, B.P.C.

Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C.

Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine

Aluminium Hydroxide Gel Dried with Magnesium Hydroxide, B.P.C.

Aluminium Hydroxide Gel Dried with Magnesium Trisilicate and Magnesium Hydroxide, B.P.C.

114

Mebhydrolin Napadisylate, B.P.C.

—

114a

Meclastine Hydrogen Fumarate

—

115

Meclozine Hydrochloride .......

Ergotamine Tartrate with Caffeine and Meclozine Hydrochloride

Second Schedule—continued

First Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Allowable Compounds (if any)

116

Meglumine ..........................

Theophylline with Meglumine

118

Methacycline .......................

—

119

Methdilazine Hydrochloride.

—

120

Methenamine Mandelate ......

—

121

Minafen ..............................

—

122

Morphine Tartrate ................

Morphine Tartrate with Tacrine

123

Nalidixic Acid, B.P.C. ..........

—

124

Naphazoline Nitrate .............

Naphazoline Nitrate with Antazoline Sulphate

125

Natamycin ...........................

Neomycin Sulphate with Hydrocortisone and Natamycin

126

Neomycin Sulphate ..............

Hydrocortisone Acetate with Neomycin Sulphate

Hydrocortisone with Neomycin Sulphate

Colistin Sulphate with Neomycin Sulphate

Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate

Kaolin with Neomycin Sulphate

Polymyxin B Sulphate with Gramicidin and Neomycin Sulphate

Polymyxin B Sulphate with Hydrocortisone and Neomycin Sulphate

Prednisolone Sodium Phosphate with Neomycin Sulphate

Bacitracin with Polymyxin B Sulphate and Neomycin Sulphate

Thonzonium Bromide with Thonzylamine Hydrochloride, Hydrocortisone Acetate, Gramicidin and Neomycin Sulphate

Gramicidin with Nystatin, Triamcinolone Acetonide and Neomycin Sulphate

Natamycin with Hydrocortisone and Neomycin Sulphate

127

Neomycin Undecenoate ........

Bacitracin Zinc with Neomycin Undecenoate

128

Neostigmine Methylsulphate

—

129

Nicotinamide .......................

Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D

130

Nitrofurantoin ......................

—

131

Noradrenaline Acid Tartrate.

—

132

Nortriptyline Hydrochloride.

—

133

Nystatin ...............................

Tetracycline, B.P.C. with a buffering agent and Nystatin

Demethylchlortetracyline with Nystatin

Tetracyline Hydrochloride with Nystatin

Gramicidin with Neomycin Sulphate

Triamcinolone Acetonide and Nystatin

Oxytetracycline Dihydrate with Nystatin

134

Nutramigen .........................

—

135

Octatropine Methylbromide

—

136

Orciprenaline Sulphate .........

—

136a

Oxytetracycline Dihydrate ....

Nystatin with Oxytetracycline Dihydrate

137

Oxytetracycline Hydrochloride

Polymyxin B Sulphate with Oxytetracycline Hydrochloride

Hydrocortisone Acetate with Oxytetracycline Hydrochloride

137a

Oxyphenisatin Acetate .........

Dioctyl Sodium Sulphosuccinate, B.P.C. with Oxyphenisatin Acetate

138

Oxethazaine .........................

Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine

139

Oxytocin .............................

Ergometrine Maleate with Oxytocin

140

Pancreatin ...........................

—

141

Pancreatin Enzyme, 4 times U.S.N.F. XII strength

—

142

Papaveretum, B.P.C. ............

Hyoscine Hydrobromide with Papaveretum, B.P.C.

143

Penicillin, Benethamine, B.P.C.

Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin

Second Schedule—continued

First Column

Second Column

Item

No.

Pharmaceutical Benefit

Allowable Compounds (if any)

144

Penicillin, Benzathine ..........

Procaine Penicillin with Potassium Penicillin and Benzathine Penicillin

145

Penicillin, Benzyl .................

Procaine Penicillin with Benzyl Penicillin

Streptomycin Sulphate with Benzyl Penicillin

Procaine Penicillin with Streptomycin Sulphate and Benzyl Penicillin

146

Penicillin, Phenoxymethyl (Benzathine, Hydrabamine, or Calcium Salt)

—

147

Penicillin, Potassium ............

Benzathine Penicillin with Procaine Penicillin and Potassium Penicillin

143

Penicillin, Procaine ..............

Benethamine Penicillin, B.P.C. with Sodium Penicillin and Procaine Penicillin

Benzathine Penicillin with Potassium Penicillin and Procaine Penicillin

Benzyl Penicillin with Procaine Penicillin

Benzyl Penicillin with Procaine Penicillin and Streptomycin Sulphate

149

Penicillin, Sodium ................

Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin

149a

Pentobarbitone .....................

Barbitone Sodium with Phenobarbitone Sodium and Pentobarbitone

150

Pertussis Vaccine .................

Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine

151

Pethidine Hydrochloride .......

Levallorphan Tartrate with Pethidine Hydrochloride

Hyoscine Hydrobromide with Pethidine Hydrochloride

152

Phenethicillin Potassium .......

—

153

Pheniramine Maleate ............

—

154

Phenytoin, B.P.C. ................

—

154a

Pholcodine ..........................

—

155

Pipenzolate Methobromide ...

—

156

Pituitary (Posterior Lobe), Powdered, B.P.C.

—

157

Plasma Substitute (Polypeptide)

157a

Polyisobutylene ...................

—

158

Polymyxin B Sulphate ..........

Chloramphenicol with Polymyxin B Sulphate

Oxytetracycline Hydrochloride with Polymyxin B Sulphate

Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate

Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin

Propylene Glycol with Acetic Acid and Polymyxin B Sulphate

Neomycin Sulphate with Hydrocortisone and Polymyxin B Sulphate

Bacitracin with Neomycin Sulphate and Polymyxin B Sulphate

Lignocaine Hydrochloride with Propylene Glycol and Polymyxin B Sulphate

159

Polyvinyl Alcohol ................

Pilocarpine Nitrate and Polyvinyl Alcohol

160

Prednisolone ........................

—

161

Prednisolone Acetate ............

—

162

Methylprednisolone .............

—

163

Prednisolone Sodium Hemisulphate

Sulphaethidole with Prednisolone Sodium Hemisulphate

164

Prednisolone Sodium Phosphate

Neomycin Sulphate with Prednisolone Sodium Phosphate

165

Prednisolone Pivalate ...........

—

166

Primidone ............................

—

167

Promethazine Hydrochloride

—

168

1,2-Propanediol Diacetate .....

Hydrocortisone with Propylene Glycol, Acetic Acid and 1,2-Propanediol Diacetate

Second Schedule—continued

First

Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Allowable Compounds (if any)

169

Pyridoxine Hydrochloride ....

Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride

170

Prosobee .............................

—

171

Riboflavine ..........................

Vitamin A with Thiamine Hydrochloride, Nicotinamide, Ascorbic Acid, Vitamin D and Riboflavine

172

Senna Fruit ..........................

—

173

Silver Nitrate, Toughened .....

—

173a

Similac Isomil ......................

—

174

Sobee ..................................

—

174a

Sodium Acid Citrate .............

—

175

Sodium Lactate ....................

Potassium Chloride with Sodium Chloride and Sodium Lactate

Potassium Chloride with Magnesium Chloride, Sodium Chloride and Sodium Lactate

Potassium Chloride with Dextrose and Sodium Lactate

Sodium Chloride with Dextrose and Sodium Lactate

Sodium Chloride with Sodium Lactate

176

Sodium Potassium Tartrate, B.P.C.

Compound Effervescent Powder, B.P.C.

177

Sodium Tauroglycocholate, B.P.C. 1954 ................................

Cascara Dry Extract with Phenolphthalein, Capsicum Oleoresin and Sodium Tauroglycocholate, B.P.C. 1954

177a

Sorbitol ...............................

Amino Acids with Sorbitol

Amino Acids with Sorbitol and Alcohol

178

Soyalac ...............................

—

180

Strychnine, B.P.C. 1959 .......

Phenolphthalein with Aloin, Dry Extract of Belladonna, Ipecacuanha and Strychnine, B.P.C. 1959

181

Sulphacetamide, B.P.C. ........

Sulphadiazine with Sulphamerazine, B.P. 1958 and Sulphacetamide, B.P.C.

182

Sulphaethidole .....................

Prednisolone Sodium Hemisulphate with Sulphaethidole

183

Sulphafurazole .....................

—

185

Sulphamethizole ..................

—

186

Sulphamethoxazole ..............

Trimethoprim with Sulphamethoxazole

187

Sulphamerazine, B.P. 1958 ...

Sulphadiazine with Sulphathiazole, B.P.C. and Sulphamerazine, B.P. 1958

Sulphadiazine with Sulphacetamide, B.P.C. and Sulphamerazine, B.P. 1958

Sulphadiazine with Sulphadimidine and Sulphamerazine, B.P. 1958

188

Sulphaphenazole, B.P.C. ......

—

189

Sulphathiazole, B.P.C. ..........

Sulphadiazine with Sulphamerazine, B.P. 1958 and Sulphathiazole, B.P.C.

190

Surgical Cement ..................

—

191

Surgical Cement Solvent ......

—

192

Tacrine ................................

Morphine Sulphate with Tacrine

Morphine Tartrate with Tacrine

193

'TERIC' N8 ..........................

Lauryl Dimethylbenzyl Ammonium Chloride with 'TERIC' N8

193a

Testosterone Decanoate ........

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

193b

Testosterone Isocaproate ......

Testosterone Propionate. B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

193c

Testosterone Phenylpropionate

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

193d

Testosterone Propionate .......

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

Second Schedule—continued

First

Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Allowable Compounds (if any)

194

Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)

Diphtheria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)

Diphtheria, Pertussis and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)

195

Tetracycline, B.P.C. .............

Tetracycline, B.P.C. with a buffering agent

Tetracycline, B.P.C. with a buffering agent and Amphotericin B

Tetracycline, B.P.C. with a buffering agent and Nystatin

196

Tetracycline Hydrochloride ..

Tetracycline Hydrochloride with Nystatin

Procaine Hydrochloride with Tetracycline Hydrochloride

197

Thiamine Hydrochloride .......

Riboflavine with Nicotinamide, Ascorbic Acid, Vitamin A, Vitamin D and Thiamine Hydrochloride

198

Thioridazine ........................

—

199

Thiotepa ..............................

—

200

Thonzonium Bromide ..........

Neomycin Sulphate with Gramicidin, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Thonzonium Bromide

201

Thonzylamine Hydrochloride

Neomycin Sulphate with Gramicidin, Hydrocortisone Acetate, Thonzonium Bromide and Thonzylamine Hydrochloride

201a

Ticmonium Iodide ...............

—

202

Tragacanth, Indian (Gum Karaya)

—

203

Triacetyloleandomycin

—

203a

Triamcinolone Acetonide .....

Gramicidin with Neomycin Sulphate, Nystatin and Triamcinolone Acetonide

204

Triclofos Sodium .................

—

205

Trifluoperazine Hydrochloride

—

206

Triglyde ...............................

—

207

Trimeprazine Tartrate, B.P.C.

—

207a

Trimethoprim ......................

Trimethoprim with Sulphamethoxazole

208

Triprolidine Hydrochloride ...

—

209

Vinyl Acetate ......................

Vinyl Pyrrolidone and Vinyl Acetate with Benzocaine

209a

Vinyl Pyrrolidone ................

Vinyl Acetate and Vinyl Pyrrolidone with Benzocaine

210

Viprynium Embonate ...........

—

211

Vitamin A ............................

Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin D and Vitamin A

212

Vitamin D ............................

Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin A and Vitamin D

THIRD SCHEDULE  Regulation 11.

Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia

1. Acepifylline

2. Acetazolamide Sodium

3. Acetohexamide

4. Acetylcholine Chloride

5. Acetylcysteine

6. Acetyl Sulphafurazole

7. Acidified Golden Syrup, A.P.F. 1955

8. Acriflavine, B.P.C. 1963

9. Acrylic Resin

10. Adrenaline Hydrochloride

11. Adrenaline Mucate

12. Agar, B.P.C. 1954

13. Albumaid XP

14. Aldosterone

16. Aloin, B.P.C.

17. Almond Oil Volatile Bitter, B.P.C. 1959

18. Aloxiprin

18a. Alprenolol Hydrochloride

19. Aluminium Acetate Solution, B.P.C.

20. Aluminium Hydroxide Mixture, A.P.F.

Third Schedule—continued

21. Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex

22. Aluminium Sodium Silicate

22a. Amantadine Hydrochloride

23. Amaranth Solution, A.P.F.

24. Amaranth Solution, Compound, A.P.F.

25. Amaranth Solution, B.P.C.

25a. Ambenonium Chloride

26. Amino Acids

27. Aminocaproic Acid

27a. Aminosalicylic Acid

27b. Amitriptyline Embonate

28. Ammonia Aromatic Spirit, B.P.C.

29. Ammonia Solution, strong, B.P.C.

29a. Ammonium Acetate Solution, strong, B.P.C.

30. Ammonium Bicarbonate, B.P.C.

32. Amphotericin B

33. Angiotensin Amide

34. Antazoline Mesylate, B.P.C.

35. Antazoline Sulphate

36. Anti-Haemophilic Factor of Animal Origin

37. Attapulgite

39. Bacitracin Zinc

41. Beeswax, Yellow, B.P.C.

42. Belladonna Suppository, B.P. 1948

43. Benedict's Solution, A.P.F.

44. Benzalkonium Chloride

45. Benzoin Compound Tincture, B.P.C.

46. Benzoin Tincture, B.P.C.

47. Benzoinated Lard, B.P.C. 1954

49. Bephenium Hydroxynaphthoate, B.P.C.

49a. Betahistine Hydrochloride

50. Betamethasone Acetate

51. Betamethasone Phosphate

53. Black Snake Antivenene

54. Biperiden Hydrochloride

55. Bismuth Subgallate, B.P.C.

57. Brompheniramine Maleate

58. Brown Snake Antivenene

59. Buchu Concentrated Infusion, B.P.C. 1954

60. Buclosamide

61. Butyl Aminobenzoate, B.P. 1953

62. Cade Oil, B.P.C.

63. Caffeine and Sodium Benzoate, B.P.C. 1954

64. Caffeine Citrate, B.P.C. 1959

65. Cajuput Spirit, B.P. 1948

66. Calcium Di-Oxytetracycline

67. Calcium Gluconogalactogluconate

68. Calcium Phosphate, B.P.C.

69. Calumba, Concentrated Infusion, B.P.1948

70. Calumba Tincture, B.P. 1948

71. Capreomycin Sulphate

72. Capsicum Ointment, B.P.C.

72a. Capsicum Olcoresin

73. Capsicum Tincture, B.P.C.

74. Carbamazepine

76. Carbenoxolone Sodium

77. Carbinoxamine Maleate

78. Cardamom Aromatic Tincture, B.P.C.

80. Catechu Tincture, B.P.C.

80a. Cephalothin Sodium

81. Cetomacrogol Emulsifying Wax, B.P.C.

82. Charcoal

83. Chloramine, B.P.C.

84. Chloramphenicol Palmitate, B.P.C.

85. Chloramphenicol Stearate

86. Chloramphenicol Succinate

87. Chlorhexidine Acetate

88. Chlorhexidine Gluconate

91a. Cholestyramine

92. Cinnamon Spirit, B.P.C. 1949

94. Clemizole Hydrochloride

95. Clemizole Tannate

97. Clopamide

98. Clorexolone

99. Clove, Concentrated Infusion, B.P.C. 1954

100. Coal Tar, B.P.C.

101. Coal Tar Solution Strong, B.P.C.

102. Cochineal Tincture, B.P. 1948

103. Coconut Oil, B.P.C. 1949

104. Codeine, B.P.C. 1954

105. Copper Sulphate, B.P.C.

106. Creosote, B.P.C. 1959

107. Cudbear Tincture, A.P.F. 1947

108  Cyclothiazide

109. Cycrimine Hydrochloride

110. Cymogran

110a. Cytosine Arabinoside Hydrochloride

111. Danthron

112. Death Adder Antivenene

113. Debrisoquine

114. Demecarium Bromide

116. Deoxycortone Pivalate, B.P. 1963

117. Desferrioxamine Mesylate

118. Deslanoside

119. Dexamethasone Metasulphobenzoate

120. Dexamethasone Sodium Phosphate

121. Dexchlorpheniramine Maleate

122. Dextrans

123. Dextriferron

124. Dibenzepin Hydrochloride

125. Dibutyl Phthalate, B.P. 1963

126. Diathanolamine Fusidate, B.P.C.

127. Diethazine Hydrochloride, B.P. 1963

128. Dihydroergotamine Mesylate

129. Dihvdroergotoxine Mesylate

130. Dihvdrostreptomycin Sulphate, B.P. 1958

131. Dimethicone, B.P.C.

132. Dimethindene Maleate

133. Dioctyl Sodium Sulphosuccinate, B.P.C.

134. Diphenylpyraline Hydrochloride

134a. Diphtheria Vaccine (Purified toxoid aluminium phosphate) diluted

134b. Diphtheria and Tetanus Vaccine, Adult

135a. Disodium Cromoglycate

138. Doxycycline Hyelate

138a. Doxylamine Succinate

138b. Droperidol

141. Ephedrine, B.P.C.

142. Ergot, Liquid Extract, B.P. 1914

143. Erythritvl Tetranitrate

144. Erythromvcin Ethyl Succinate

145. Erythromvcin Glucoheptonate

146. Ervthromvcin Lactobionate

148. Ethanolamine, B.P.C.

149. Ethanolamine Oleate

150. Ether Nitrous Spirit, B.P.C. 1959

151. Ethoxzolamide

Third Schedule—continued

152. Ethylidene Dicoumarin

153. Ethylnoradrenaline Hydrochloride

154. Ethyloestrenol

156. Ferric Hydroxide

157. Ferrous Aminoacetosulphate

158. Ferrous Carbonate Saccharated, B.P.C. 1959

159. Ferrous Phosphate Compound, Syrup B.P.C.

161. Flumethasone Pivalate

162. Fluorouracil Sodium

164. Fluphenazine Enanthate

164a, Flurandrenolone Acetonide

166. Framycetin Sulphate

167. Galactomin, Formula No. 17

168. Galactomin, Formula No. 19

169. Gall and Opium Ointment, B.P.C. 1963

170. Gelsemium Tincture, B.P.C.

171. Gentamicin Sulphate

172. Gentian Concentrated Compound Infusion, B.P. 1963

173. Ginger Syrup, B.P.C.

173a. Glibenclamide

174. Glucagon Hydrochloride

175. Glucose Indicator-Blood

175a. Glucose Indicator-Urine

176. Glycerophosphate Compound Syrup, A.P.F.

177. Glycopyrronium Bromide

178. Glymidine

179. Goat's Milk, Dehydrated

180. Goat's Milk, Whole (Sterilised)

181. Gramicidin

182. Guaiphenesin, B.P.C.

185. Hamamelis Liquid Extract, B.P.C.

186. Hexocyclium Methylsulphate

187. Haemodialysis Fluid—Concentrate

188. Hydrargaphen

189. Hydrocyanic Acid, Dilute.B.P.C.1954

190. Hydromorphone Hydrochloride

191. Hydroxyprogesterone

192. Hyoscine Methobromide

193. Hypophosphorous Acid, Dilute, B.P.C.1963

194. Hypromellose 4500

196. Indomethacin

196a. Influenza Vaccine—Sub Unit type (Desoxycholate Treated)

196b. Injection of Amino Acids with Sorbitol and Alcohol

196c. Injection of Casein Hydrolysate with Laevulose and Alcohol

196e. Injection of Dextran with Dextrose

196F.  Injection of Potassium Chloride with Sodium Lactate and Dextrose

196g. Injection of Sodium Chloride with Potassium Chloride, Calcium Chloride and Dextrose

196h. Injection of Sodium Chloride with Sodium Lactate and Dextrose

197. Insect Allergen Extract—Honey Bee

197a. Insect Allergen Extract—Jumper Ant

197b. Insect Allergen Extract—Paper Wasp

198. Insulin Injection, specially purified

199. Insulin Isophane Injection, specially purified

200. Insulin Injection, Special P (Pig)

201. Invert Sugar

202. Iodoform, B.P.C. 1954

203. Ipecacuanha and Opium Powder, B.P.C.

204. Iron Polymaltose Complex

205. Isoprenaline Hydrochloride

206. Isopropainide Iodide

208. Kanamycin Sulphate, B.P.C.

210. Lanatoside-C

211. Lauryl Dimethyl Benzyl Ammonium Chloride

212. Lavender Spike Oil, B.P.C.

213. Lead Subacetate Dilute Solution

214. Lead Subacetate Strong Solution, B.P.C.

214a. Levodopa

214b. Lemon Oil Terpeneless, B.P.C.

215. Lemon Tincture, B.P. 1958

215a. Leucovorin

216. Lincomycin Hydrochloride

217. Lipopancreatin

218. Lobelia Ethereal Tincture, B.P.C.

219. Lofenalac

220. Lypressin

221. Magenta, B.P.C.

222. Magnesium-Aluminium Hydroxide

223. Magnesium Hydroxide, B.P.C.

223a. Maphenide Acetate

223b. Mebeverine Hydrochloride

224. Mebhydrolin Napadisylate, B.P.C.

225. Meclastine Hydrogen Fumarate

226. Medroxyprogesterone Acetate

227. Melphalan

228. Mepenzolate Bromide

229. Mercaptomerin Sodium

230. Mercuric Chloride, B.P.C.

231. Metaraminol Bitartrate

233. Methacycline

234. Methaqualone Hydrochloride

236. Methdilazine Hydrochloride

237. Methenamine Mandelate

238. Methenolone Acetate

240. Methoxamine Hydrochloride, B.P.C.

241. Methsuximide

242. Methyclothiazide

243. Methylphenobarbitone, B.P.C. 1963

244. Methylprednisolone Acetate

244a. Methyprednisolone Sodium Succinate

245. Methysergide Maleate

246. Metyrapone

247. Minafen

248. Morphine Tartrate

249. Myrrh Tincture, B.P.C.

250. Nalidixic Acid, B.P.C.

251. Nandrolone Hexoxyphenyl Propionate

252. Natamycin

253. Neomycin Undecenoate

255. Nitrazepam

256. Nitromin

257. Nutramigen

258. Octatropine Methylbrormide

259. Oestradiol Dipropionale, B.P.C. 1954

260. Oestrone, B.P.C. 1954

26l. Oily Opthalmic Vehicle, A.P.F. 1955

262. Orange Peel Compound Concentrated Infusion, B.P.C. 1954

263. Orange Peel, Concentrated Infusion, B.P.C.

264. Orange Syrup, B.P.C.

265. Orange Tincture, B.P.C.

266. Oxethazaine

Third Schedule—continued

266a. Oxprenolol Hydrochloride

267. Oxycodone Pectinate

268. Oxymel, B.P.O.

269. Oxymel of Squill, B.P.C.

270. Oxymetholone

270a. Oxyphenisatin Acetate

271. Oxyphenenium Bromide

272. Oxytetracycline.

273. Oxytocin

274. Pancreatin Enzyme, U.S.N.F. XII

275. Papaveretum, B.P.C.

277. Paraben Ophthalmic Phosphate Buffer, A.P.P. 1955

278. Paraben Ophthalmic Vehicle, A.P.F.1955

279. Paraffin Liquid Light, B.P.C. 1963

280. Paramethasone Acetate

282. Pectin

283. Penicillinase

284. Penicillin Benethamine, B.P.C.

285. Pentaerythritol Tetranitrate, diluted.B.P.C.

285a. Pentazocine Lactate

286.

 Penthienate Methobromide

286a. Pentobarbitone

286b. Peritoneal Dialysis Solution with Dextrose

287. Peru Balsam, B.P.C.

288. Phenazone, B.P.C.

290. Phenformin Hydrochloride

291. Pheniramine Maleate

292. Pheniramine Para-Aminosalicylate

293. Phenol Ointment, B.P. 1948

294. Phenoxymethylpenicillin, Benzathine

295. Phenoxymethylpenicillin, Hydrabamine

296. Phensuximide, B.P.C.

297. Phenthimentonium

298. Phenytoin, B.P.C.

299. Phosphoric Acid Dilute, B.P. 1963

300. Phthalylsulphacetamide

301. Physostigmine, B.P.C.

302. Pilocarpine Hydrochloride

303. Pipenzolate Methobromide

304. Pituitary Hormone, Follicle-stimulating, Human

305. Pituitary Hormone, Growth, Human

306. Pituitary (Posterior Lobe) Powdered, B.P.C.

306a. Plasma Substitute (Polypeptide)

306b. Polyisobutylene

307. Polyoestradiol Phosphate

308. Polyvinyl Alcohol

311. Potassium Chlorate, B.P.C.

312. Potassium Effervescent Tablets

313. Potassium Perchlorate

314. Prednisolone Acetate

315. Prednisolone Sodium Succinate

316. Prednisolone Sodium Hemisulphate

317. Prednisolone Tertiary Butyl Acetate

318. Procarbazine Hydrochloride

318a. Prochlorperazine

319. 1,2-Propanediol Diacetate

319a. Proscillaridin

320. Prosobee

321. Protriotyline Hydrochloride

322. Pumilio Pine Oil, B.P.O.

323. Pyridine Aldoxime Methiodide

324. Quillaia Tincture. B.P.C.

325. Quinethazone

326. Quinidine Bisulphate

327. Raspberry Syrup, B.P.C.

328. Rauwolfia Alkaloids

328a. Rauwolfia Serpentina, B.P.C.

329. Red Back Spider Antivenene

330. Rolitetracyeline

331. Rosemary Oil, B.P.C.

332. Salicylamide

333. Secbutobarbitone Sodium

334. Senega, Concentrated Infusion, B.P.C. 1959

335. Senega, Concentrated Infusion, B.P.C. 1963

336. Senna Compound Mixture, B.P.C. 1959

337. Senna. Concentrated Infusion, B.P.C. 1959

338. Senna Fruit Extract (Standardised)

339. Siberian Fir Oil, B.P.C. 1949

340. Silver Protein, B.P.C.

341. Silver Protein Mild, B.P.C.

341a. Similac Isomil

342. Snake Bite Antivenene—Polyvalent

343. Sobee

314. Sodium Folate

345. Sodium Lactate

345a. Sodium Lactate Compound Injection, B.P. with Dextrose

346. Sodium Nitrite, B.P.C.

347. Sodium Nitroprusside

348. Sodium Potassium Tartrate, B.P.C.

349. Sodium Tauroglycocholate, B.P.C. 1954

351. Sorbide Nitrate

352. Sorbitol

353. Soyalac

356. Squill Tincture, B.P.C.

357. Stanolone

358. Stanozolol

359. Stearic Acid, B.P.C.

359a. Stilboestrol Diphosphate

360. Stone Fish Antivenene

360a. Streptokinase

361. Strophanthus Tincture, B.P. 1948

362. Strychnine, B.P.C. 1959

363. Sulphacetamide, B.P.C.

363a. Sulphaethidole

365. Sulphamerazine, B.P. 1958

366. Sulphamethoxazole

367. Sulphaphenazole. B.P.C.

368. Sulphasalazine

368a. Sulphasymazine

360. Sulphathiazole, B.P.C.

170. Sulphurated Potash, B.P.C.

371. Sulphuric Acid, Dilute, B.P.C.

372. Sulphur Sublimed, B.P.C.

373. Surgical Cement

374. Surgical Cement Solvent

376. Syrup Glucose Liquid, B.P.C. 1963

377. Tacrine

378. Taipan Antivenene

379. Tar Ointment. B.P.C. 1959

380. Tartrazine. B.P.C. 1954

381. TERIC N 8

38lA. Testosterone Decanoate

382. Testosterone Enanthate

382a. Testosterone Isocaproate

383. Tetracosactrin

384. Tetraecycline. B.P.C.

384a Thiabendazole

Third Schedule—continued

384b. Thiethylperazine Malate

385. Thiethylperazine Maleate

386. Thioridazine

388. Thonzonium Bromide

389. Thonzylamine Hydrochloride

390. Thyrotrophin

391. Tiemonium Iodide

392. Tiger Snake Antivenene

393. Titanium Dioxide, B.P.C.

394. Tolazamide

395. Tolu Tincture, B.P.C. 1959

396. Tragacanth, Indian (Gum Karaya)

397. Tragacanth Mucilage

399. Tretamine

400. Triacetyloleandomycin

401. Tridehexethyl Chloride

402. Triethanolamine, B.P.C.

403. Triglyde

404. Trimeprazine Tartrate, B.P.C.

405. Trimethoprim

405a. Trimipramine Maleate

405b. Trimipramine Mesylate

406. Trolnitrate Phosphate

407. Typhoid Vaccine

408. Typhoid and Cholera El Tor Combined Vaccine

409. Urethane, B.P. 1963

411. Valerian Ammoniated Tincture, B.P.C.1963

412. Vanillin

413. Vasopressin Tannate

415. Vinblastine Sulphate

416. Vincristine Sulphate

417. Vinegar of Squill, B.P.C.

417a. Vinyl Acetate

417b. Vinyl Pyrrolidone

418. Vitamin A

419. Vitamin D

420. Zinc Gelatin, B.P.C.

FOURTH SCHEDULE

Regulation 12.

Additives

1. Acetone, B.P.C.

2. Alcohol (95%), B.P.

3. Arachis Oil, B.P.

4. Amethocaine Hydrochloride, B.P.

5. Camphor, B.P.

6. Caraway Oil, B.P.C.

7. Carmine Solution, A.P.F.

8. Citronella Oil, B.P.C.

9. Chloroform, B.P.

9a. Concentrated Anise Water, B.P.C.

9b. Concentrated Cinnamon Water, B.P.C

9c. Concentrated Peppermint Water, B.P.

10. Cottonseed Oil, B.P.

12. Dextrose Monohydrate, B.P.

13. Dilute Alcohols, B.P.

14. Ether Anaesthetic, B.P.

14a. Eucalyptol, B.P.C.

14b. Eucalyptus Oil, B.P.

15. Honey–Purified, B.P.C.

16. Maize Oil, B.P.

17. Olive Oil, B.P.

17A. Peppermint Oil, B.P.

20. Sodium Thiosulphate, B.P.C.

21. Solution of Burnt Sugar, B.P.C.1959

22. Spirit, Methylated, Industrial, B.P.

22a. Syrup of Pholcodine Citrate, B.P.C.1959

22b. Turpentine Oil, B.P.

23. Xylene, B.P.C. 1949

FIFTH SCHEDULE  Regulation 14.

Pharmaceutical Benefits the Prescribing or Which is Subject to Conditions and Restrictions

First Column

Second Column

Item

No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

1

Acetylcysteine......................

Cystic Fibrosis (mucoviscidosis)

2

(1) Aspirin with Paracetamol and Caffeine Tablets

Any disease or condition in a pensioner

(2) Aspirin with Codeine Phosphate and Pentobarbitone Sodium Tablets

3

Acrylic Resin ...........................

Ileostomy or colostomy conditions

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

4

Albumaid XP .........................

With the written authority of the Director-General, Phenylketonuria

5

Aldosterone ...........................

With the written authority of the Director-General, treatment of an acute crisis in adrenal cortical hypofunction (including Addison's disease and salt-losing congenital adrenal hypoplasia)

6

Alprenolol Hydrochloride Injection.............................

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm, aortic

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

7

Alprenolol Hydrochloride Tablets

With the written authority of the Director-General,

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm, aortic

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

7A

Amantadine Hydrochloride .....

With the written authority of the Director-General, treatment of Parkinson's disease in conjunction with Levodopa

8

Ambenonium Chloride ...........

Myasthenia gravis

9

Aminocaproic Acid ................

Any disease or condition in a patient receiving treatment in or at an approved hospital

10

Aminosalicylic Acid ..............

Tuberculosis

11

Amphotericin B Injection .......

Systemic mycoses

13

(1) Ampicillin Capsules, B.P..

Infections of the car or respiratory tract where they cannot be safety and effectively treated with sulphonamides, phenoxymethylpenicillin or phenethicillin

(2) Ampicillin Injections, Tablets and Suspension ..................

Gram-negative infections where ampicillin appears to be the most suitable drug

Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to ampicillin or where the patient is sensitive to sulphonamides

Broad spectrum antibiotic treatment of patients undergoing steroid therapy or recently subjected to steroid therapy

Bacterial endocarditis

Meningitis

Infections in pregnant women or in children where these cannot be safely and effectively treated with sulphonamides, phenoxymethylpenicillin or phenethicillin, excluding infections due to penicillin resistant staphylococci

14

Ascorbic Acid Tablets, B.P. ....

Any disease or condition in a pensioner

15

Azathioprine ..........................

With the written authority of the Director-General, azathioprine therapy for a person who has been discharged from an approved hospital and received that therapy while a patient in the hospital

Fifth Schedule—continued

First Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

17

Benzathine Penicillin, B.P. .............

Prophylaxis of recurrent streptococcal infections (including rheumatic fever)

18

Benzoin Compound Tincture, B.P.C. aerosol spray

Ileostomy or colostomy conditions

19

Benzylpenicillin Injection, 5,000,000 units

Bacterial endocarditis or septicaemia

20

(1) Benzylpenicillin Tablets, B.P.

Prophylaxis of recurrent streptococcal infections, (including rheumatic fever)

(2) Benzylpenicillin Capsules

21

Benzylpenicillin Injection, 10,000,000 units

Bacterial endocarditis or septicaemia

Gastrointestinal surgery

22

(1) Benzylpenicillin with Streptomycin Sulphate

Endocarditis due to streptococcus faccalis or streptococcus viridans

(2) Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate

23

Betahistine Hydrochloride ..............

Meniere's Syndrome

24

Betamethasone Acetate and Betamethasone Injection

Intra-articular use

With the written authority of the Director-General, pre-operative and post-operative prophylactic therapy for those patients undergoing or recently subjected to steroid therapy

25

Buclosamide with Salicylic Acid

For the treatment of diseases of the car

26

Buclosamide, Salicylic Acid and Hydrocortisene Acetate

For the treatment of diseases of the car

27

Busulphan Tablets, B.P. .................

Treatment in malignant neoplasia

28

(1) Calciferol Tablets, Strong, B.P.

Any disease or condition in a pensioner

(2) Calciferol, B.P. ........................

With the written authority of the Director-General—

Hypoparathyroidism

Osteomalacia following gastrectomy

Vitamin D-resistant rickets

29

Calcium Aminosalicylate ...............

Tuberculosis

30

Capreomycin Sulphate ...................

Tuberculosis

31

Carbamazepine ..............................

Epilepsy

Trigeminal neuralgia

32

Carbenicillin Sodium .....................

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that carbenicillin is the most appropriate therapeutic agent

33

Carbenoxolone Sodium ..................

Any disease or condition in a patient receiving treatment in or at an approved hospital

34

Cephaloridine ................................

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephaloridine is the most appropriate therapeutic agent

35

Cephalothin Sodium ......................

Any disease or condition in a patient receiving treatment in or at an approved hospital

36

Charcoal Tablets ...........................

Ileostomy or colostomy conditions

37

Chlorambucil Tablets, B.P. ............

Treatment in malignant neoplasia

38

Chloramme Deodorant Tablets and Powder

Ileostomy or colostomy conditions

39

(1) Chloramphenicol Capsules, B.P.

Bacterial meningitis

(2) Chloramphenicol Injections ......

Intraocular infections

(3) Chloramphenicol Oral Suspension

Rickettsioses

Typhoid

The treatment of other serious infections in a patient where it is established by appropriate bacteriological testing that Chloramphenicol is the only suitable antibiotic listed as a pharmaceutical benefit for use in treating the infection in the patient

40

Chlorotrianisene Tablets ................

Carcinoma of the prostate

41

(1) Chloropromazine Hydrochloride, B.P.

Any disease or condition in a pensioner

(2) Chlorpromazine Injection, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued

First Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

41—cont.

(3) Chlorpromazine Tablets, B.P.

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, B. P., Chlorpromazine Injection, B.P. or Chlorpromazine Tablets, B.P.

With the written authority of the Director-General—

Hereditary chorea (Huntington's)

Malignant neoplasia (Late stage)

Radiation sickness

The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

42

Cholestyramine .....................

With the written authority of the Director-General—

Bile salt malabsorption associated with ileal resection or proven ileal disease

Pruritis associated with partial biliary obstruction not responding to other therapy

Initial treatment with cholestyramine of proven hyperbetalipoproteinaemia (type II) not responding to other therapy

A second or subsequent course of treatment for proven hyperbetalipoproteinaemia (type II) in patients who respond to treatment with cholestyramine but do not respond to other therapy

43

Clofibrate ..............................

With the written authority of the Director-General—

Diabetic retinopathy (exudative)

Initial treatment with clofibrate of hyperlipidaemia not responding to dietary therapy

A second or subsequent course of treatment for hyperlipidaemia where significant lowering of serum cholesterol subsequent to inital treatment with clofibrate has been established by laboratory report

44

(1) Cloxacillin Sodium, B.P. ...

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Cloxacillin Capsules, B.P.

With the written authority of the Director-General, life threatening infection where bacteriological evidence confirms the presence of penicillinase-producing staphylococci

45

(1) Codeine Phosphate with Aspirin Soluble Tablets

Any disease or condition in a pensioner

(2) Codeine Phosphate with Aspirin Tablets

(3) Codeine Phosphate with Aspirin and Paracetamol Soluble Tablets

(4) Codeine Phosphate with Aspirin and Paracetamol Tablets

(5) Codeine Phosphate with Aspirin, Paracetamol and Caffeine Tablets

47

Colistin Sulphomethate Sodium, B.P., for injection

Pyocyaneus infection, other gram-negative infections where no other drug is effective

48

Cyanocobalamin Injection, B.P.

Pernicious anaemia and other proven Vitamin B-12 deficiencies

Post gastrectomy treatment

Fifth Schedule—continued

First Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

48—cont.

Sub-acute combined degeneration of the cord

Neuroblastoma

49

(1) Cycloserine Tablets, B.P. ....

Tuberculosis

(2) Cycloserine Capsules, B.P.

50

Cymogran ...............................

With the written authority of the Director-General, phenylketonuria

51

(1) Cyproheptadine Hydrochloride, B.P.

Allergic rhinitis

Allergic dermatosis

(2) Cyproheptadine Tablets, B.P.

Migraine

52

Cytosine Arabinoside Hydrochloride

Any disease or condition in a patient receiving treatment in or at an approved hospital

53

Deodorant Detergent Solution (Lauryldimethyl Benzyl Ammonium Chloride and 'TERIC' N8)

Ileostomy or colostomy conditions

54

(1) Deoxycortone Acetate Injection, B.P.

Adrenal cortical hypofunction including Addison's disease

(2) Deoxycortone Pivalate Injection, B.P.

Total adrenalectomy

(3) Deoxycortone Acetate Implants, B.P.

(4) Deoxycortone Acetate Tablets

55

Desferrioxamine Mesylate ........

Acute iron poisoning

Hepatolenticular degeneration

57

(1) Dextromoramide Tablets, B.P.

Treatment in malignant neoplasia

(2) Dextromoramide Tartrate, B P.

58

Diazepam Injection ..................

Any disease or condition in a pensioner

Any disease or condition in a patient receiving treatment in or at an approved hospital

Electrical conversion of cardiac arrythmias (cardioversion)

Endoscopy

Epilepsy

Minor operative procedures

Motor neurone lesion

Premedication induction of anaesthesia

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Diazepam

With the written authority of the Director-General—

Hereditary chorea (Huntington's)

Malignant neoplasia (late stage)

Radiation sickness

The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

59

Diazepam Syrup and 10 mg. Tablets

Any disease or condition in a pensioner

Any disease or condition in a patient receiving treatment in or at an approved hospital

Epilepsy

Motor neurone lesion

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Diazepam

With the written authority of the Director-General—

Hereditary chorea (Huntington's)

Fifth Schedule—continued

First

Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

59—Cont.

Malignant neoplasia (late stage)

Radiation sickness

The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

60

Diazepam Tablets 2 mg, and 5 mg.

Any disease or condition in a pensioner

Any disease or condition in a patient receiving treatment in or at an approved hospital

Epilepsy

Motor neurone lesion

Multiple sclerosis

Stiff-man syndrome

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Diazepam

With the written authority of the Director-General—

Hereditary chorea (Huntington's)

Malignant neoplasia (late stage)

Radiation sickness

The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

61

Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride

Vomiting in pregnancy

62

Dienoestrol Cream ................

Any disease or condition in a pensioner

64

(1) Dihydroergotoxine Mesylate tablets

For the treatment of patients who have suffered an attack of paralytic poliomyelitis

(2) Dihydroergotoxine Mesylate injection

65

Dihydrotachysterol ................

Hypoparathyroidism

67

Dimethicone Aerosol Spray ...

Ileostomy or colostomy conditions

68

Dimethicone Creams .............

Use with surgical appliances

69

(1) Dioctyl Sodium Sulphosuccinate with Danthron

Any disease or condition in a pensioner

(2) Dioctyl Sodium Sulphosuccinate with Oxyphenisatin Acetate

70

Disodium Cromoglycate ........

With the written authority of the Director-General—

The prevention of attacks of asthma in the case of a patient whose attacks of asthma have been sufficiently severe and frequent to interfere seriously with his normal activities of life and whose recurrences of asthma—

(a) were not controlled by adequate use of bronchodilators and other recognized methods of prevention and treatment; or

(b) required the continuous use of corticosteroid therapy

72

Droperidol ............................

Any disease or condition in a patient receiving treatment in or at an approved hospital

74

Ethacrynic Acid ....................

Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome

Fluid retention associated with other conditions and not responding to thiazides

Fifth Schedule—continued

First Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

75

Ethinyloestradiol Tablets, B.P..

Any disease or condition in a pensioner

Carcinoma of the breast post-menopausal

Carcinoma of the prostate

Hereditary telangiectasis

Premature menopause that is surgically induced

Turner's syndrome

76

Ethionamide ...........................

Tuberculosis

77

Ethisterone Tablets, B.P. .........

Turner's syndrome

78

Ethyloestrenol .........................

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Intermittent use for patients on long term treatment with corticosteroids

Osteomalacia following gastrectomy

79

Fludrocortisone Tablets, B.P. ...

Adrenal cortical hypoplasia including Addison's disease

Total adrenalectomy

81

Fluorouracil Sodium ...............

Treatment in malignant neoplasia

82

Fluoxymesteronc Tablets, B.P..

Eunuchism

Eunuchoidism

Carcinoma of the breast

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Proven aplastic anaemias

83

Fluphenazine Enanthate ...........

Any disease or condition in a patient receiving treatment in or at an approved hospital

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with either or both of the following pharmaceutical benefits—

Fluphenazine Enanthate

Fluphenazine Hydrochloride

With the written authority of the Director-General—

Hereditary chorea (Huntington's)

Malignant neoplasia (late stage)

Radiation sickness

The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

84

Fluphenazine Hydrochloride ....

Any disease or condition in a pensioner

Any disease or condition in a patient receiving treatment in or at an approved hospital

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with either or both of the following pharmaceutical benefits—

Fluphenazine Enanthate

Fluphenazine Hydrochloride

With the written authority of the Director-General—

Hereditary chorea (Huntington's)

Malignant neoplasia (late stage)

Radiation sickness

The treatment of a mental disorder in a person who has been discharged from an approved hospital

Fifth Schedule—continued

First Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

84–cont.

at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

85

(1) Folic Acid, B.P. ....................

Cystic fibrosis

Proven folic acid deficiency

(2) Folic Acid Tablets, B.P. 5 mg.

Sprue or the sprue-like syndrome

86

Folic Acid Tabids, B.P. 0.5 mg.

Cystic fibrosis

Pregnancy

87

Framycetin Sulphate Tablets .......

Bowel sterilization preparatory to major surgery

88

Frusemide Tablets, B.P. ..............

Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome

Fluid retention associated with other conditions and not responding to thiazides

89

Galactomin Formula No. 17 ........

With the written authority of the Director-General—

Galactosaemia.

Conditions needing an extreme restriction of lactose in the diet of a patient under the age of four years

90

Galactomin Formula No. 19 ........

With the written authority of the Director-General, glucose-galactose malabsorption

91

Gentamicin Sulphate ..................

Any disease or condition in a patient receiving treatment in or at an approved hospital

92

Glucose Indicator—Blood ..........

With the written authority of the Director-General, diabetes mellitus, where blood sugar levels cannot be determined to be within a satisfactory range by urine testing

93

Goat's Milk, Dehydrated .............

With the written authority of the Director-General, cow's milk allergy in children under the age of four years

94

Goat's Milk, Whole (Sterilized) ...

With the written authority of the Director-General, cow's milk allergy in children under the age of four years

95

(1) Griseofulvin, B.P. .................

With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination or Wood's Light

(2) Griseofulvin Tablets, B.P. ......

97

Halibut Liver Oil Capsules .........

Any disease or condition in a pensioner

98

Haloperidol ................................

Any disease or condition in a pensioner

Any disease or condition in a patient receiving treatment in or at an approved hospital

The treatment of a mental disorder in a person who has after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Haloperidol

With the written authority of the Director-General—

Hereditary chorea (Huntington's)

Malignant neoplasia (late stage)

Radiation sickness

The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

100

Hydrocortisone Acetate Injection, B.P.

Intra-articular use

101

Hydrocortisone Sodium Succinate Injection

Acute adrenal cortical hypofunction due to medical or surgical crisis

Prophylactic therapy before, during and after surgical procedures for patients undergoing or recently subjected to steroid therapy

Fifth Schedule—continued

First Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

102

Hydroxocobalamin Injection, B.P.

Pernicious anaemia and oilier proven Vitamin B-12 deficiencies

Post gastrectomy treatment

Sub-acute combined degeneration of the cord

Neuroblastoma

103

Hydroxyprogesterone Caproate ......

Carcinoma of the endometrium

Progesterone deficiency proved by hormonal assay, by lateral wall smear or by endometrial biopsy

104

Idoxuridine ...................................

Infections caused by Herpes Simplex Virus

105

Influenza Vaccine ..........................

For prophylaxis of pensioners only

106

Insect Allergen Extract–Honey Bee

With the written authority of the Director-General, score constitutional reaction to bee stings

106a

Insect Allergen Extract Jumper Ant

With the written authority of the Director-General, severe constitutional reaction to jumper and stings

107

Insect Allergen Extract—Paper Wasp

With the written authority of the Director-General, severe constitutional reaction to wasp stings

108

Isoniazid Tablets, B.P.

Tuberculosis

109

Isoprenaline Hydrochloride Tablets, 30 mg.

Stokes-Adams syndrome

110

Kanamycin Sulphate Capsules, Injections and Oral Solution

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the most appropriate antibiotic

111

Leucovorin ...................................

Antidote to folic acid antagonists

112

Levodopa ......................................

With the written authority of the Director-General, treatment of Parkinson's disease

113

Levorphanol Tartrate .....................

Obstetrical use

Severe intractable pain

114

Lignocaine Injection, B.P. ..............

Cardiac arrhythmias

115

Lincomycin Hydrochloride ............

Gram positive coccal infections where these cannot be safely and effectively treated with a penicillin

Osteomyelitis

116

Liothyronine Tablets, B.P. .............

Myxoedema

117

Lofenalac ......................................

With the written authority of the Director-General, phenylketonuria

118

Lypressin Nasal Spray ...................

Diabetes insipidus

119

Maphenide Acetate ........................

Any disease or condition in a patient receiving treatment in or at an approved hospital

120

Medroxyprogesterone Acetate Tablets, 2.5 mg.

Carcinoma of the endometrium

121

Medroxyprogesterone Acetate

Carcinoma of the endometrium

Tablets, 10 mg.

Precocius puberty

122

Medroxyprogesterone Acetate

Carcinoma of the breast

Tablets, 100 mg

Carcinoma of the endometrium

Hypernephroma

123

Medroxyprogesterone Acetate

Carcinoma of the endometrium

Injections

Hypernephroma

Progesterone deficiency proven by hormonal assay, by lateral wall smear or by endometrial biopsy

124

Melphalan .....................................

Treatment in malignant neoplasia

125

Mercaptopurine Tablets, B.P. .........

Allergic granulomatous angitis

Lupus erythematosus

Nephrotic syndrome

Periarteritis (Nodosa)

Treatment in malignant neoplasia

126

(1) Methandienone Tablets, B.P.

With the written authority of the Director-General—

(2) Methenolone Acetate ................

Intermittent use for corticosteroid-induced osteoporosis

Intermittent use for patients on long-term treatment with corticosteroids

127

Methicillin Sodium, B.P. for Injection

Proven or suspected staphylococcal septicaemia

128

Methotrexate Tablets .....................

Treatment in malignant neoplasia

Fifth Schedule—continued

First Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

129

Methotrexate Injections ............................................... ...............................................

Treatment in malignant neoplasia

129A

Methylprednisolone Acetate ...............................................

With the written authority of the Director-General—

Retention Enema ...............................................

Colitis, ulcerative, proven by sigmoidoscopy or radiological report

Proctitis, proven by sigmoidoscopy

130

Methylprednisolone Acetate Injection

Intra-articular use

131

(1) Methyltestosterone Tablets, B.P.

Carcinoma of the breast

Eunuchism

(2) Methyl testosterone, B.P. ...............................................

Eunuchoidism

Klinefelter's syndrome (seminiferous tubule dysgenesis)

132

Methysergide Maleate ...............................................

Treatment of severe recalcitrant migraine where other treatment has failed

133

Metyrapone ...............................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

134

Minafen ...............................................

With the written authority of the Director-General, phenylketonuria

135

Morphine Sulphate, B.P. with Tacrine Tablets

Severe intractable pain

136

Mustine Hydrochloride Injection

Treatment in malignant neoplasia

137

Nalidixic Acid ...............................................

Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to nalidixic acid or where the patient is sensitive to sulphonamides

138

Nandrolone Decanoate ...............................................

Carcinoma of the breast

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Intermittent use for patients on long-term treatment with corticosteroids

Severe osteoporosis due to proven pancreatitis

139

Nandrolone Hexoxyphenyl Propionate

Carcinoma of the breast

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Intermittent use for patients on long-term treatment with corticosteroids

140

Nandrolone Phenylpropionate Injection, B.P.

Carcinoma of the breast

With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis

142

Neomycin Sulphate Powder ...............................................

With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis)

143

Neomycin Tablets, B.P. ...............................................

Bowel sterilization preparatory to major surgery

Encephalopathy, hepatic

Enteropathogenic E. coli infections in infants

144

Nicotinic Acid Tablets, B.P. ...............................................

Any disease or condition in a pensioner

146

(1) Nitrofurantoin Tablets, B.P. ...............................................

Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to nitrofurantoin or where the patient is sensitive to sulphonamides

(2) Nitrofurantoin Oral Suspension

147

Nitromin ...............................................

Treatment in malignant neoplasia

148

Norethisterone Acetate, B.P. ...............................................

Carcinoma of the breast

148a

Norethisterone Tablets, B.P. ...............................................

Endometriosis

Metrophathia haemorrhagica

Precocious puberty

149

Nutramigen ...............................................

With the written authority of the Director-General—

Cow's milk allergy in children under the age of four years

Fifth Schedule—continued

First

Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

149—cont.

Cystic Fibrosis (mucoviscidosis)

Galactosaemia

Lactose intolerance

152

Oxprenolol Hydrochloride Tablets

With the written authority of the Director-General—

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm, aortic

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

153

Oxprenolol Hydrochloride Injection

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm, aortic

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

154

Oxycodone Pectinate ................................................

Treatment in malignant neoplasia

155

Oxymetholone ................................................

With the written authority of the Director-General, proven aplastic anaemias

156

(1) Pancreatin, B. P. ................................................

Cystic Fibrosis (mucoviscidosis)

(2) Pancreatin Enzyme 4 X

Following pancreatico-duodenectomy

U.S.N.F. XII

Pancreatic steatorrhoea

(3) Pancrelipase

157

(1) Paracetamol Mixture ................................................

Any disease or condition in a pensioner

(2) Paracetamol Tablets, B.P.

158

Paracetamol with Codeine Phosphate and Pentobarbitone Sodium

Any disease or condition in a pensioner

159

(l) Paraffin Liquid Emulsion ................................................

Any disease or condition in a pensioner

(2) Paraffin Liquid Emulsion with Phenolphthalein

161

Penicillamine ................................................

With the written authority of the Director-General—

Acute heavy metal intoxication

Cystinosis

Cystinuria with calculus formation

Haemoglobinuria, paroxysmal cold

Wilson's disease (hepatolenticular degeneration)

163

Phytomenadione Injection, 10 mg. per ml.

Antidote to anticoagulants

Haemorrhage diathesis associated with malabsorption

164

Phytomenadione Injection, B.P., 1 mg. in 1 ml.

Antidote to anticoagulants

Suspected cerebral trauma of the new born

Hemorrhagic diathesis associated with malabsorption

Hemorrhagic disease of the new born

165

Pituitary, Posterior Lobe, Insufflation

Diabetes insipidus

166

Plasma Substitute (Polypeptide) ................................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

166a

Polyisobutylene ................................................

Ileostomy or colostomy conditions

167

Polymyxin B. Sulphate Powder ................................................

With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis)

Fifth Schedule—continued

First Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

168

Polyoestradiol Phosphate ...........

Carcinoma of the breast

Carcinoma of the prostate

169

Prednisolone Sodium Phosphate

With the written authority of the Director-General—

Retention Enema and Suppository

Ulcerative colitis proven by sigmoidoscopy or radiological report

Proctitis proven by sigmoidoscopy

170

(1) Prednisolone Acetate Injection

Intra-articular use

(2) Prednisolone Butyl Acetate Injection

171

Prednisolone Sodium Succinate Injection

Acute adrenal cortical hypofunction due to any medical or surgical crisis

Prophylactic therapy before, during and after surgical procedures for patients undergoing or recently subject to steroid therapy

172

Procarbazine Hydrochloride .......

Treatment in malignant neoplasia

173

(1) Prochlorperazine ..................

Meniere's Syndrome

(2) Prochlorperazine Tablets, B.P.

174

Progesterone .............................

Progesterone deficiency proven by hormonal assay, by lateral wall smear or by endometrial biopsy

175

Propranolol Injection, B.P. .........

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm, aortic

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

176

Propranolol Tablets, B.P. ...........

With the written authority of the Director-General—

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm, aortic

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

176a

Proscillaridin ............................

Patients intolerant of oral forms of prepared digitalis, digoxin and lanatoside C

177

Prosobee ...................................

With the written authority of the Director-General—

Galactosaemia

Homocystinuria

Lactose intolerance

Milk allergy in children under the age of four years

178

Pyrazinamide ............................

Any disease or condition in a patient receiving treatment in or at an approved hospital

179

(1) Pyridostigmine Injection, B.P.

Myasthenia gravis

(2) Pyridostigmine Tablets, B.P..

180

Pyridoxine Hydrochloride Tablets

Homocystinuria

Radiation sickness

Treatment and prophylaxis of peripheral neuritis caused or likely to be caused by isoniazid therapy

Sideroblastic (refractory anaemia)

Proven pyridoxine responsive anaemia

With the written authority of the Director General, primary hyperoxaluria

182

Riboflavine Tablets ...................

Any disease or condition in a pensioner

182a

Senna Fruit Extract (standardised)

Any disease or condition in a pensioner

Fifth Schedule—continued

First Column_Column

Third Column

Item

No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

182b

Similac Isomil .........................

With the written authority of the Director-General—

Galactosaemia

Homocystinuria

Lactose intolerance

Milk allergy in children under the age of four years

183

Sobee .....................................

With the written authority of the Director-General—

Galactosaemia

Homocystinuria

Lactose intolerance

Milk allergy in children under the age of four years

184

(1) Sodium Aminosalicylate Tablets, B.P.

Tuberculosis

(2) Sodium Aminosalicylate Injection

(3) Sodium Aminosalicylate Cachets

(4) Sodium Aminosalicylate Granules

(5) Sodium Aminosalicylate with Isoniazid, B.P.

185

Sodium Folate .........................

Proven folic acid deficiency

Sprue or the sprue-like syndrome

186

(1) Sodium Fusidate ................

With the written authority of the Director-General,

(2) Diethanolamine Fusidate ....

the treatment of serious staphylococcal infections in a patient where it is established by appropriate bacteriological testing that Sodium Fusidate or Diethanolamine Fusidate in combination with another antibiotic is an appropriate therapy

187

Soyalac ...................................

With the written authority of the Director-General—

Galactosaemia

Homocystinuria

Lactose intolerance

Milk allergy in children under the age of four years

189

Spironolactone Tablets, B.P. ....

With the written authority of the Director-General—

To supplement other diuretics when these have proved inadequate

Myasthenia gravis

Primary hyperaldosteronism

190

Stanolone ...............................

Carcinoma of the breast

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Intermittent use for patients on long-term treatment with corticosteroids

191

Stanozolol ..............................

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Intermittent use for patients on long-term treatment with corticosteroids

192

Stilboestrol Diphosphate ..........

Carcinoma of the prostate

193

Streptokinase ..........................

Any disease or condition in a patient receiving treatment in or at an approved hospital

194

Sulphasalazine ........................

Ulcerative colitis

196

(1) Surgical Cement ................

Ileostomy or colostomy conditions

(2) Surgical Cement Solvent ....

For use with surgical appliances

197

(1) Testosterone Propionate, B.P. with Testosterone Phenyl propionate, B.P. and Testosterone Iocaproate

Eunuchoidism

Eunuchism

Klinefelter's syndrome (seminiferous tubule dysgenesis)

(2) Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

Carcinoma of the breast

Fifth Schedule—continued

First

Column

Second Column

Third Column

Item

No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

197—cont.

(3) Testosterone Implants, B.P.

(4) Testosterone Enanthate

(5) Testosterone Propionate Injection, B.P.

198

Tetanus Antitoxin, B.P. (Bovine)

Patients who have previously received an injection of equine serum

200

Thiamine Hydrochloride Tablets, B.P.

Any disease or condition in a pensioner

201

Thiethylperazine Maleate Tablets and Suppositories

Radiation sickness

Nausea resulting from cytotoxic therapy

202

(1) Thioridazine Tablets, B.P. ..

Any disease or condition in a pensioner

(2) Thioridazine

Any disease or condition in a patient receiving treatment in or at an approved hospital

The treatment of a mental disorder in a person who has, after treatment for a. mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with either or both of the following pharmaceutical benefits—

Thioridazine

Thioridazine Tablets, B.P.

With the written authority of the Director-General—

Hereditary chorea (Huntington's)

-

Malignant neoplasia (late stage)

Radiation sickness

The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

203

Thyrotrophin ..........................

Any disease or condition in a patient receiving treatment in or at an approved hospital

204

Tragacanth, Indian (Gum Karaya)...........................................

Ileostomy or colostomy conditions

206

Tretamine ...............................

Treatment in malignant neoplasia

207

Triacetyloleandomycin ............

Amoebiasis

Brucellosis

Leptospirosis

Lymphogranuloma venereum

Pneumonia due to mycoplasma pneumoniae

Pneumonia, staphylococcal

Psittacosis

Rickettsioses

Staphylococcal septicaemia

Actinomycosis, trachoma, or any bacterial or spirochaetal infections where these cannot be safely and effectively treated by sulphonamides, phenoxymethylpenicillin or phenethicillin

207a

Triamcinolone Acetonide Injection

With the written authority of the Director-General, treatment of keloids

208

(1) Trifluoperazine Tablets, B.P.

Any disease or condition in a pensioner

(2) Trifluoperazine Hydrochloride, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Trifluoperazine Hydrochloride, B.P. or Trifluoperazine Tablets, B.P.

With the written authority of the Director-General—

Hereditary chorea (Huntington's)

Malignant neoplasia (late stage)

Fifth Schedule—continued

First Column_Column

Third Column

Item

No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

208—cont.

Radiation sickness

The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

209

Triglyde ........................................

With the written authority of the Director-General, proven malabsorption

211

Trimethoprim with Sulphamethoxazole

Any disease or condition in a patient receiving treatment in or at an approved hospital

Respiratory tract infections or urinary tract infections where positive bacteriological evidence shows trimethoprim with sulphamethoxazole to be effective

214

(1) Vinblastine Sulphate .................

Treatment in malignant neoplasia

(2) Vincristine Sulphate

215

Vinyl Pyrrolidone and Vinyl Acetate with Benzocaine Aerosol Spray

Ileostomy or colostomy conditions

216

(1) Viomycin Sulphate ...................

Tuberculosis

(2) Viomycin Sulphate Injection, B.P.

217

Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D Tablets and Capsules

Any disease or condition in a pensioner

Printed by Authority by the Government Printer of the Commonwealth of Australia

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0